John P. Reilly

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi, Roland E. Schmieder, Felix Mahfoud et al. · The Lancet · 2018 · 689 citations · Full text

Hypertension, Urology, Radiance-htn Solo +9

Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization

Issam Moussa, Lloyd W. Klein, Binita Shah et al. · Journal of the American College of Cardiology · 2013 · 621 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Artery Disease +8

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi, Kintur Sanghvi, Manish Saxena et al. · The Lancet · 2021 · 375 citations · Full text

Hypertension, Urology, Renal Function +9

Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the society for cardiovascular angiography and interventions (SCAI)

Issam Moussa, Lloyd W. Klein, Binita Shah et al. · Catheterization and Cardiovascular Interventions · 2013 · 174 citations

Heart Failure, Cardiovascular Angiography, Coronary Artery Disease +16

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Deepak L. Bhatt, Muthiah Vaduganathan, David E. Kandzari et al. · The Lancet · 2022 · 166 citations

Hypertension, Urology, Resistant Hypertension +10